- Moderna raises full-year guidance and achieves first quarterly profit since 2024
- Strong Overseas Sales of COVID-19 Vaccines: Moderna (MRNA.US) Turns a Profit in Q3 and Significantly Raises Full-Year Revenue Guidance
- Enviri Publishes Q3 2026 Earnings Call Transcript
- CONSTRUCTION PARTNERS, INC. <ROAD.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $90 FROM $130
- Arch Biopartners Arranges CAD 900,000 Private Placement
- COGNEX CORPORATION <CGNX.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $57 FROM $74
- CHORD ENERGY CORPORATION <CHRD.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $197 FROM $195
- AIRBNB, INC. : ROSENBLATT SECURITIES RAISES TARGET PRICE TO $230 FROM $220
- SABESP Debt Rises R$ 6.3 Billion to R$ 46.44 Billion at End-September
- "Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?
- IRHYTHM HOLDINGS, INC <IRTC.O>: WELLS FARGO CUTS TARGET PRICE TO $135 FROM $150
- Accor Shareholder Parvus Considers Seeking Board, Management Changes
- Marti Technologies Sets Third-Quarter Results Announcement
- FCPE Crédit Agricole Classique Raises Stake, Voting Rights in Crédit Agricole Above 5%
- MICROCHIP TECHNOLOGY <MCHP.O>: ROSENBLATT SECURITIES CUTS TARGET PRICE TO $115 FROM $120
- JPMorgan Cuts Exail Technologies Stake to 4.88%, Below 5% Threshold
- J.P. Morgan's Voting Rights in Inventiva Fall Below 5% to 4.99%
- BUZZ - As Eli Lilly expands access to weight loss drugs through its platform, “Hims & Hers” is emerging
- ALBEMARLE : TRUIST SECURITIES CUTS TARGET PRICE TO $170 FROM $185
- Former Governor of the Bank of Spain, De Cos, Appointed as President of the European Central Bank
- AGIOS PHARMACEUTICALS, INC. : TRUIST SECURITIES CUTS TARGET PRICE TO $35 FROM $37
- APPLIED OPTOELECTRONICS, INC. : ROSENBLATT SECURITIES CUTS TARGET PRICE TO $115 FROM $220
- TC ENERGY CORPORATION <TRP.TO>: BMO RAISES TARGET PRICE TO C$102 FROM C$99
- AIRBNB, INC. : STONEX RAISES TARGET PRICE TO $215 FROM $180
- ITT INC <ITT.N>: BMO CUTS TARGET PRICE TO $243 FROM $273
- KURA SUSHI USA, INC. <KRUS.O>: STONEX CUTS TARGET PRICE TO $55 FROM $85
- Ubiquiti Q1 revenue, profit jump; warns of margin pressure
- QUEBECOR INC. <QBRb.TO>: BMO RAISES TARGET PRICE TO C$80 FROM C$75
- LIVE NATION ENTERTAINMENT, INC. <LYV.N>: STONEX RAISES TARGET PRICE TO $220 FROM $215
- Driven Brands delays third-quarter filing amid financial restatement
- Euro dips as weak Eurozone data, BoJ tightening bets bolster Japanese Yen
- ARDENT HEALTH INC : BMO RAISES TARGET PRICE TO $16 FROM $11
- APPLOVIN : DEUTSCHE BANK RAISES TARGET PRICE TO $475 FROM $450
- EVERCOMMERCE <EVCM.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $7 FROM $12
- GLOBALFOUNDRIES <GFS.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $60 FROM $75
- MKS INC. <MKSI.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $240 FROM $385
- EVERCOMMERCE <EVCM.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $7 FROM $12
- WILLSCOT HOLDINGS CORPORATION <WSC.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $26 FROM $30
- CARDINAL HEALTH INC <CAH.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $265 FROM $261
- 10X GENOMICS <TXG.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $50 FROM $70
- ACADIA PHARMACEUTICALS INC. : DEUTSCHE BANK CUTS TARGET PRICE TO $30 FROM $31
- AGILON HEALTH : DEUTSCHE BANK RAISES TARGET PRICE TO $139 FROM $116
- MCKESSON CORP <MCK.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $1120 FROM $913
- A10 NETWORKS : DEUTSCHE BANK CUTS TARGET PRICE TO $24 FROM $28
- AIRBNB : DEUTSCHE BANK RAISES TARGET PRICE TO $220 FROM $200
- VERISK ANALYTICS <VRSK.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $227 FROM $200
- GOODYEAR TIRE & RUBBER <GT.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $4 FROM $5
- ARRAY TECHNOLOGIES : DEUTSCHE BANK CUTS TARGET PRICE TO $4.6 FROM $4.7
- AIR PRODUCTS & CHEMICALS : DEUTSCHE BANK RAISES TARGET PRICE TO $325 FROM $320
- WYNN RESORTS <WYNN.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $116 FROM $119
- SIX FLAGS ENTERTAINMENT <FUN.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $17 FROM $20
- PLANET FITNESS : DEUTSCHE BANK RAISES TARGET PRICE TO $58 FROM $54
- RALPH LAUREN <RL.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $462 FROM $452
- PRIMO BRANDS CORPORATION : DEUTSCHE BANK RAISES TARGET PRICE TO $22 FROM $21
- TEXAS ROADHOUSE <TXRH.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $210 FROM $200
- Emera, Canadian Utilities seek US energy regulator approval for merger
- SUN LIFE FINANCIAL INC <SLF.TO>: BMO CUTS TARGET PRICE TO C$118 FROM C$123
- Starwood Property Trust 3Q Distributable EPS 31c >STWD
- Optimum Communications Q3-26 adjusted EBITDA falls 7% year over year to $773.7 million
- GLOBAL PAYMENTS INC <GPN.N>: BMO RAISES TARGET PRICE TO $88 FROM $83
- ADVANCE AUTO PARTS INC : BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $41 FROM $42
- SOLVENTUM CORPORATION <SOLV.N>: BMO RAISES TARGET PRICE TO $92 FROM $84
- EZTec Announces Dividend of R$ 0.07314516455 per Share
- MDA SPACE LTD <MDA.TO>: BMO CUTS TARGET PRICE TO C$55 FROM C$68
- Enbridge sets incoming CEO Harradence’s base salary at US$ 1.2 million
- BrenX Adjourns Special Shareholder Meeting Over Lack of Quorum
- Anika Therapeutics Q3 net loss narrows 87% to $311,000; Q3 revenue rises 10% to $30.59 million
- Herbalife CFO Participates in One-on-One Meetings at Stephens Annual Investment Conference
- Treace Medical Q3 2026 Net Loss Narrows 23% to $12.6 Million
- NeoGenomics to Participate in Stephens and Piper Sandler Investor Conferences
- Brookfield Infrastructure Partners Q3 net income drops 84% to USD 69 million
- Brookfield Asset Management Q3 non-GAAP fee-related earnings rise 15% to USD 864 million
- Ring Energy forecasts 2027 capital spending of $135 million to $165 million
- Kinder Morgan Expects 2026 Adjusted EPS More Than 13% Above Budget
- Bunker Hill completes acquisition of Silver47 Exploration
- TeraWulf Targets About 85% NOI Margin on Contracts
- Eastport Critical Metals identifies copper-mineralized trenches spanning 12 km at Copper Snake
- Sylvamo 3Q Adj EPS $1.33 >SLVM
- BRIEF-Eli Lilly & Hims & Hers Health Announce Agreement To Expand Access To Zepbound & Foundayo
- Moderna: 3Q Rev Rose 29%, Primarily Driven by Higher Covid Vaccine Sales in Intl Markets, Supported by Deliveries Under Long-Term Strategic Government Partnerships >MRNA
- Moderna 3Q International Markets Revenue $533M >MRNA
- Moderna: Now Expect Total Revenue Growth of 15%-25% in 2026, Exceeding Previous Outlook of Up to 10% Growth >MRNA
- Moderna Now Sees 2026 Research & Development Expenses of About $2.7B Vs Prior View About $2.9B >MRNA
- Moderna Now Expects Year-End 2026 Cash and Investments of About $8.1B-$8.3B Vs Prior View $4.7B-$5.2B >MRNA
- Moderna: Intend to Engage With Health Authorities to Determine mRNA-1403 Norovirus Vaccine Candidate Program's Path Forward >MRNA
- Moderna 3Q Rev $1.31B >MRNA
- Utz Brands 3Q Loss $24.3M >UTZ
- Utz Brands 3Q Adj EPS 10c >UTZ
- Bloomin' Brands 3Q Adj Loss/Shr 17c >BLMN
- Bloomin' Brands 3Q Rev $944.3M >BLMN
- Delek Logistics Partners 3Q EPS 85c >DKL
- Utz Brands 3Q Sales $369.2M >UTZ
- --Earnings Flash (BIP) Brookfield Infrastructure Partners Posts Q3 Revenue $6.56B
- Enbridge's Q3 Adjusted Earnings, Revenue Increase
- --Earnings Flash (BIP) Brookfield Infrastructure Partners Posts Q3 FFO $0.91 a Unit, vs. FactSet Est of $0.90
- Wedbush Raises Price Target on CytomX Therapeutics to $12 From $11, Keeps Outperform Rating
- --Earnings Flash (PSQL) Pasqal Posts Q3 Revenue of 3.3M Euros, vs. FactSet Est of 3.5M Euros
- --Earnings Flash (ENB) Enbridge Posts Q3 Operating Revenue CA$21.08B, vs. FactSet Est of CA$13.7B
- Atmus Filtration Q3 Adjusted Earnings, Net Sales Rise; 2026 Outlook Raised
- Source Energy Services Q3 Loss Narrows, Sales Rise
